Search for content and authors
 

Molecular properties of active ingredients Impact on bioavailability The biopharmaceutics classification system

Aleksander P. Mazurek 

Medical University of Warsaw, Department of Drug Chemistry, Banacha 1, Warszawa 02-097, Poland
Narodowy Instytut Lekow (NIL), Chełmska 30/34, Warszawa 00-725, Poland

Abstract

The main target of Biopharmaceutic Classification System (BCS) is to identify molecular determinants that have an impact on bioavailability of studied agents. Solubility and permeability are two properties that have an effect on compounds bioavailability which is the most important for biological activity of drugs in humans. Experimental determination of those parameters is cumbersome and frequently impossible. Therefore we calculated for selected active ingredients the parameters which describe both solubility and the tendency to cross biological membranes. The free enthalpy of solvation (∆Gsolv) in water and organic solvents (e.g. chloroform or chlorobenzene)  and electrostatic potential range give valuable information on solubility, polarity, lipophilicity of compounds and explain solute-solvent interaction phenomena. Moreover we determined and compared experimental and theoretical log P values which, as first approximation, describe lipophilicity and permeability of pharmacological substances.
The results also usefully serve as description of properties relevant to Biopharmaceutics Classification System (BCS) and seem to be promising tool for fast and clear classification of chemical substances within BCS. Characteristics, like solubility and permeability are considered when active substances are classified into group I-IV. We managed, as an example, to propose BCS categorization for antifungal drugs, as a step to improve the BCS system at the international level.

 

Legal notice
  • Legal notice:
 

Related papers

Presentation: Invited oral at VII Multidyscyplinarna Konferencja Nauki o Leku, by Aleksander P. Mazurek
See On-line Journal of VII Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2010-03-16 09:47
Revised:   2010-03-16 09:47